|Pfizer Inc -- USA Stock|| |
USD 35.50 0.010000 0.030000%
Group President - Vaccines, Oncology and Consumer Healthcare Business
Mr. Albert Bourla is Group President Pfizer Innovative Health of the company. He was Group President, Global Innovative Pharma Business from February 2016 until June 2016 and Group President, Vaccines, Oncology and Consumer Healthcare since January 2014. President and General Manager of Established Products Business Unit from December 2010 until December 2013. Area President Europe, Africa, Asia and Pacific of Pfizer Animal Health from 2009 until November 2010. Area President Europe, Africa and Middle East of Pfizer Animal Health from 2005 until 2009.
Age: 54 President Since 2016
212 733-2323 www.pfizer.com
Albert Bourla Latest Insider Activity
The company has Return on Asset of 5.27 %
which means that on every $100 spent on asset it made $5.27 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE)
of 13.68 %
implying that it generated $13.68 on every 100 dollars invested.
The company has 43.87 B in debt with debt to equity (D/E) ratio of 74.7 . This implies that the company may be unable to create cash to meet all of its financial commitments. Pfizer Inc has Current Ratio of 1.31 which is typical for the industry and considered as normal.
Pfizer Inc. discovers, develops, manufactures, and sells healthcare solutions worldwide. Pfizer Inc (PFE) is traded on New York Stock Exchange in USA. It is located in NEW YORK, U.S.A and employs 97,900 people. Pfizer is listed under Pharmaceutical Products category by Fama And French industry classification.